Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by LithLoveron Jun 15, 2023 4:14pm
178 Views
Post# 35498823

Thank you Mr Riggs

Thank you Mr RiggsApproval of an ordinary resolution authorizing and approving the issuance of 10,745,077 common shares of the Corporation in connection with the conversion of US$562,065 Notes with 95% for.


Filed 2023-06-15 11:49
 
Tx date 2023-06-08
$SZLS
StageZero Life Sciences Ltd.
Riggs, Rory
4 - Director of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange
$752,155
+10,745,077 vol
$0.07 each
23,267,983
-----------------------------------
Maybe the CEO and rest of the board should take a look at Riggs and what supporting thye company looks like.  The CEO can't sell or market and not sure what the rest of the board brings to the table.  You would think with their connections there would be some deal or partnership by now.  

Time for a new board and new CEO.  Other than Rory Riggs of course.
<< Previous
Bullboard Posts
Next >>